ARG1 and metabolic dysfunction-associated steatotic liver disease: Another potential prognostic marker in metabolic syndrome/NASH-associated human liver cancer is arginase 1 (ARG1), whose expression is downregulated in NAFLD/NASH-HCC (Table 1 and Table 2).